A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

10.1007/s10637-007-9085-0

Saved in:
Bibliographic Details
Main Authors: Ma, B., Lam, K.C., Mo, F., Chan, A.T.C., Zee, B., Mok, T., Goh, B.C., Soo, R., Wang, L.Z., Tan, E.H., Leong, S.S.
Other Authors: PHARMACOLOGY
Format: Article
Published: 2011
Subjects:
3-AP
Gemcitabine
Methemoglobinemia
Non-small-cell lung cancer
Triapine
Online Access:http://scholarbank.nus.edu.sg/handle/10635/27208
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1007/s10637-007-9085-0

Similar Items